These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 23754337

  • 1. Investigation of the effect of the uneven distribution of CYP3A4 and P-glycoprotein in the intestine on the barrier function against xenobiotics: a simulation study.
    Watanabe T, Maeda K, Nakai C, Sugiyama Y.
    J Pharm Sci; 2013 Sep; 102(9):3196-204. PubMed ID: 23754337
    [Abstract] [Full Text] [Related]

  • 2. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS, Neuhoff S, Jamei M, Rostami-Hodjegan A.
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption.
    Badhan R, Penny J, Galetin A, Houston JB.
    J Pharm Sci; 2009 Jun; 98(6):2180-97. PubMed ID: 18855913
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption--theoretical approach.
    Ito K, Kusuhara H, Sugiyama Y.
    Pharm Res; 1999 Feb; 16(2):225-31. PubMed ID: 10100307
    [Abstract] [Full Text] [Related]

  • 9. Prediction of nonlinear intestinal absorption of CYP3A4 and P-glycoprotein substrates from their in vitro Km values.
    Tachibana T, Kato M, Sugiyama Y.
    Pharm Res; 2012 Mar; 29(3):651-68. PubMed ID: 21913031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV, Sateesh K, Panchagnula R.
    Mol Pharm; 2005 Mar; 2(1):12-21. PubMed ID: 15804173
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV, Panchagnula R.
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional interaction of intestinal CYP3A4 and P-glycoprotein.
    Kivistö KT, Niemi M, Fromm MF.
    Fundam Clin Pharmacol; 2004 Dec; 18(6):621-6. PubMed ID: 15548232
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A.
    Choi JS, Choi JS, Choi DH.
    Biopharm Drug Dispos; 2014 Oct; 35(7):382-90. PubMed ID: 24903704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.